Altair Trading Co
⚠️ Moderate Risk
FEI: 3003890311 • Lattakia • SYRIA
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
INSANITARY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health.
NEEDS FCE
It appears the manufacturer is not registered as a low acid canned food or acidified food manufacturer pursuant to 21 CFR 108.25(c)(1) or 108.35(c)(1).
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
SALMONELLA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain Salmonella, a poisonous and deleterious substance which may render it injurious to health.
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NO PROCESS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the manufacturer's failure to file a scheduled process demonstrates that the product is not being manufactured under the mandatory provisions of 21 CFR Part 108 and therefore appears to have been manufactured, processed, or packed, under insanitary conditions whereby it may have been rendered injurious to health.
EXCESS SUL
The article appears to contain excessive sulfites, a poisonous and deleterious substance which may render it injurious to health.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/9/2007 | 21GHP09OLIVES (PIT FRUIT) | 62NEEDS FCE | New York District Office (NYK-DO) |
| 5/9/2007 | 21GHP09OLIVES (PIT FRUIT) | 62NEEDS FCE | New York District Office (NYK-DO) |
| 5/4/2007 | 21GHP09OLIVES (PIT FRUIT) | 62NEEDS FCE | New York District Office (NYK-DO) |
| 8/24/2006 | 21GHY09OLIVES (PIT FRUIT) | Minneapolis District Office (MIN-DO) | |
| 8/24/2006 | 24BGH70LENTILS, DRIED OR PASTE | Minneapolis District Office (MIN-DO) | |
| 8/24/2006 | 02DDT07RICE, BASMATI, PROCESSED (PACKAGED) | Minneapolis District Office (MIN-DO) | |
| 8/24/2006 | 28AFH10CARDAMON, WHOLE (SPICE) | Minneapolis District Office (MIN-DO) | |
| 8/24/2006 | 28AFH10CARDAMON, WHOLE (SPICE) | Minneapolis District Office (MIN-DO) | |
| 8/24/2006 | 16AEE45TUNA (ALBACORE, YELLOWFIN, BLUEFIN, SKIPJACK, ETC.) | Minneapolis District Office (MIN-DO) | |
| 8/24/2006 | 21GMY09OLIVES (PIT FRUIT) | 249FILTHY | Minneapolis District Office (MIN-DO) |
| 8/24/2006 | 54EGT99HERBALS & BOTANICAL TEAS, N.E.C. | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 8/24/2006 | 28BAH99SPICES, GROUND, CRACKED, ETC., N.E.C. | 9SALMONELLA | Minneapolis District Office (MIN-DO) |
| 10/25/2003 | 21BFH99MIXED FRUIT, DRIED OR PASTE, N.E.C., | 245EXCESS SUL | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Altair Trading Co's FDA import refusal history?
Altair Trading Co (FEI: 3003890311) has 13 FDA import refusal record(s) in our database, spanning from 10/25/2003 to 5/9/2007.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Altair Trading Co's FEI number is 3003890311.
What types of violations has Altair Trading Co received?
Altair Trading Co has been cited for 12 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Altair Trading Co come from?
All FDA import refusal data for Altair Trading Co is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.